Zhi Quan Xiang

The Wistar Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.8kcitations29works9.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(11), Rabies epidemiology and control(8), Virology and Viral Diseases(7), Viral Infections and Outbreaks Research(7), Immunotherapy and Immune Responses(6)

Publications29 total

Rabies glycoprotein engineering for improved stability and expression
Vaccine·2025Open Access
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Nature Communications·2025· 27 citedOpen Access
A phase 1 study of SHR-1905, a long-acting anti-TSLP monoclonal antibody, in healthy subjects and patients with asthma
2024· 1 cited
454 Checkpoint modification of early T cell activation provides enhanced anti-tumor activity and survival benefits in a fast-growing preclinical tumor challenge model
Regular and Young Investigator Award Abstracts·2023Open Access
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
The Lancet Microbe·2022· 26 citedOpen Access
Pathogenicity of Ureaplasma urealyticum serotype 1 and 8 in the genital tract of female BALB/c mice
Chinese Journal of Dermatology·2014
B cell responses to the 2011/12-influenza vaccine in the aged
Aging·2013· 13 citedOpen Access
Recombinant Vaccine to HIV-1 Gag A Simian Replication-Defective Adenoviral
2013
Next Generation of Rabies Vaccines
Elsevier eBooks·2013· 3 cited
List of Contributors
Elsevier eBooks·2013
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals
AIDS·2012· 7 citedOpen Access
Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens
The Journal of Immunology·2009· 46 citedOpen Access
A Preclinical Animal Model to Assess the Effect of Pre-existing Immunity on AAV-mediated Gene Transfer
Molecular Therapy·2009· 41 citedOpen Access
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines
Blood·2007· 216 citedOpen Access
A CD46-binding Chimpanzee Adenovirus Vector as a Vaccine Carrier
Molecular Therapy·2007· 36 citedOpen Access
A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
The Journal of Immunology·2003· 210 citedOpen Access
Development of novel antibacterial peptides that kill resistant isolates
Peptides·2002· 104 cited
A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line
Cellular Immunology·2002· 16 cited
Phosphopeptide models of the C-terminal basic domain of p53
2002
Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor
Journal of General Virology·2002· 65 cited
page 1 of 2Next →

Frequent Co-authors

Hildegund C.J. Ertl(21), Wynetta Giles‐Davis(6), László Ötvös(5), Hildegund C.J. Ertl(5), James M. Wilson(4), Dongming Zhou(4), Guangping Gao(4), Nia Tatsis(3), Julie C. Fitzgerald(3), Shih‐Wen Lin(3), InSug O‐Sullivan(3), Magdalena Blaszczyk‐Thurin(3), Steven L. Spitalnik(2), William H. Wunner(2), Jun Cheng(2), Arturo Reyes‐Sandoval(2), Scott E. Hensley(2), Ang Bian(2), César López‐Camacho(2), George N. Pavlakis(2)